Sadhna R Vora MD

Senior Physician Editor, UpToDate; Instructor in Medicine, Harvard Medical School

Massachusetts General- Brigham Cancer Institute, Waltham52 Second AvenueWaltham, MA 02451
Phone+1 781-487-6100

Dr. Vora is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vora's full profile Already have an account?

Summary

Dr. Sadhna Vora is an oncologist based in North Waltham, MA. She earned her medical degree from Yale School of Medicine in 2006 and completed her residency in Internal Medicine at Massachusetts General Hospital in 2009. She pursued a fellowship in Hematology and Medical Oncology from 2009 to 2012 at institutions affiliated with Mass General Brigham, including the Dana-Farber Cancer Institute. Dr. Vora's research has been published extensively, including influential works on the sensitivity of PIK3CA-mutant breast cancer to inhibitors, which have been highly cited in scientific literature.

Education & Training

Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2009 - 2012
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2009
Yale School of MedicineClass of 2006

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2008 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

1 citations
Erratum for the research article: mTORC1 inhibition is required forsensitivity to PI3K p110a inhibitors in PIK3CA-mutant breast cancer (Science Translational Medicine ...
Moshe Elkabets, Sadhna Vora, Dejan Juric, Natasha Morse, Mari Mino-Kenudson
Science Translational Medicine. 2018-11-14
370 citations
CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors
Sadhna Vora, Dejan Juric, Nayoon Kim, Mari Mino-Kenudson, Tiffany Huynh
Cancer Cell. 2014-07-14
272 citations
mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in PIK3CA-Mutant Breast Cancer
Moshe Elkabets, Sadhna Vora, Dejan Juric, Natasha Morse, Mari Mino-Kenudson
Science Translational Medicine. 2013-07-31